FDA Inspection 1102472 — Anthony J. Windebank, M.D., Clinical Investigator

Anthony J. Windebank, M.D., Clinical Investigator — FEI 3015627649

The FDA completed an inspection of Anthony J. Windebank, M.D., Clinical Investigator on September 19, 2019 in Rochester, MN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 19, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Rochester, MN (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance